C Neil Lyons - Net Worth and Insider Trading
C Neil Lyons Net Worth
The estimated net worth of C Neil Lyons is at least $0 dollars as of 2024-09-20. C Neil Lyons is the CFO & Treasurer of Regenerx Biopharmaceuticals Inc and owns about 300 shares of Regenerx Biopharmaceuticals Inc (RGRX) stock worth over $0. Details can be seen in C Neil Lyons's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that C Neil Lyons has not made any transactions after 2010-06-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of C Neil Lyons
C Neil Lyons Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, C Neil Lyons owns 3 companies in total, including Cleveland BioLabs Inc (CBLI) , Regenerx Biopharmaceuticals Inc (RGRX) , and Statera BioPharma Inc (STAB) .
Click here to see the complete history of C Neil Lyons’s form 4 insider trades.
Insider Ownership Summary of C Neil Lyons
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CBLI | Cleveland BioLabs Inc | 2015-04-22 | Chief Financial Officer |
RGRX | Regenerx Biopharmaceuticals Inc | 2010-06-11 | Chief Financial Officer |
STAB | Statera BioPharma Inc | 2011-09-01 | Chief Financial Officer |
C Neil Lyons Latest Holdings Summary
C Neil Lyons currently owns a total of 1 stock. C Neil Lyons owns 300 shares of Regenerx Biopharmaceuticals Inc (RGRX) as of June 11, 2010, with a value of $0.
Latest Holdings of C Neil Lyons
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RGRX | Regenerx Biopharmaceuticals Inc | 2010-06-11 | 300 | 0.00 | 0 |
Holding Weightings of C Neil Lyons
C Neil Lyons Form 4 Trading Tracker
According to the SEC Form 4 filings, C Neil Lyons has made a total of 0 transactions in Regenerx Biopharmaceuticals Inc (RGRX) over the past 5 years. The most-recent trade in Regenerx Biopharmaceuticals Inc is the acquisition of 200 shares on June 11, 2010, which cost C Neil Lyons around $5,600.
Insider Trading History of C Neil Lyons
- 1
C Neil Lyons Trading Performance
GuruFocus tracks the stock performance after each of C Neil Lyons's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by C Neil Lyons is 3.57%. GuruFocus also compares C Neil Lyons's trading performance to market benchmark return within the same time period. The performance of stocks bought by C Neil Lyons within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how C Neil Lyons's insider trading performs compared to the benchmark.
Performance of C Neil Lyons
C Neil Lyons Ownership Network
C Neil Lyons Owned Company Details
What does Cleveland BioLabs Inc do?
Who are the key executives at Cleveland BioLabs Inc?
C Neil Lyons is the Chief Financial Officer of Cleveland BioLabs Inc. Other key executives at Cleveland BioLabs Inc include Vice President of Finance Christopher Zosh , Principal Financial Officer John Edward Szydlo , and President & CMO Langdon L Miller .
Cleveland BioLabs Inc (CBLI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cleveland BioLabs Inc (CBLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cleveland BioLabs Inc (CBLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cleveland BioLabs Inc (CBLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cleveland BioLabs Inc Insider Transactions
C Neil Lyons Mailing Address
Above is the net worth, insider trading, and ownership report for C Neil Lyons. You might contact C Neil Lyons via mailing address: C/o Cleveland Biolabs Inc, 73 High Street, Buffalo Ny 14203.